Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1991 | 12-1990 | 09-1990 | 06-1990 | 03-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,136 | 9,321 | 10,983 | 11,349 | 7,203 |
| Receivables | 1,089 | 758 | 625 | 656 | 1,369 |
| Inventories | 405 | 368 | 442 | 450 | 370 |
| Other current assets | 337 | 341 | 383 | 254 | 238 |
| TOTAL | $9,968 | $10,788 | $12,432 | $12,708 | $9,180 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 636 | 649 | 663 | 676 | 473 |
| TOTAL | $636 | $649 | $663 | $676 | $473 |
| Total Assets | $12,681 | $13,504 | $15,214 | $15,560 | $11,797 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 501 | 422 | 461 | 776 | 406 |
| Accrued Expenses | 1,363 | 1,245 | 1,670 | 1,220 | 1,226 |
| Other current liabilities | 216 | 400 | 959 | 477 | 222 |
| TOTAL | $2,080 | $2,067 | $3,090 | $2,473 | $1,855 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,080 | $2,067 | $3,090 | $2,473 | $1,855 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 10 | 10 | 10 | 9 |
| Retained earnings | -9,517 | -8,712 | -8,004 | -7,017 | -7,302 |
| Other shareholders' equity | 487 | 521 | 761 | 1,710 | 1,710 |
| TOTAL | $10,601 | $11,436 | $12,124 | $13,088 | $9,943 |
| Total Liabilities And Equity | $12,681 | $13,503 | $15,214 | $15,561 | $11,797 |